Sr./Executive, Medical Director

Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company dedicated to creating new standards of care for patients.

We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune disease. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class.

Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.

We push conventional boundaries from candidate selection to differentiated therapeutic, applying rigorous go/no go criteria at each stage of development to fast-track only the most promising molecules to the clinic and, ultimately, commercialization.

With deep scientific expertise, our teams exercise creativity and urgency to deliver on our promise to bring new therapeutic solutions to patients.

Summary

We seek an experienced and passionate clinical immunologist or neurologist to conduct clinical trials for autoimmune diseases. The ideal candidate will have a solid clinical immunologist or neurologist practice and clinical research background and a genuine interest in advancing novel treatments for patients with autoimmune diseases.

Position Responsibilities

• Develop and execute the clinical development strategy for the company assets in autoimmune disease indications.
• Lead the design and implementation of clinical trials, overseeing all study aspects from protocol development to study completion.
• Provide medical expertise and guidance throughout the trial, including patient screening, enrollment, and management.
• Collaborate with cross-functional teams, including clinical research scientists, clinical operations, regulatory affairs, and biostatistics, to ensure the successful execution of the trial.
• Ensure compliance with regulatory requirements, Good Clinical Practice (GCP) guidelines, and study protocols.
• Review and interpret clinical trial data, contribute to data analysis and interpretation, and prepare study reports for regulatory submissions.
• Actively participate in study team meetings, investigator meetings, and other relevant forums to discuss trial progress, challenges, and opportunities.
• Maintain open communication with study participants, investigators, and site staff to address any medical or clinical issues that may arise during the trial.
• Disseminate study findings through presentations and publications.
  
  

Candidate Requirements

• Medical degree (MD or equivalent) in clinical immunology or neurology practice and clinical research with a minimum of 5 years of experience in the biopharma industry.
• Strong understanding of clinical trial design, execution, and regulatory requirements, with experience designing and conducting Phase 1-3 clinical trials.
• Demonstrate expertise in autoimmune diseases, with a deep understanding of disease pathophysiology, treatment landscape, and clinical endpoints.
• Excellent communication and interpersonal skills, with the ability to effectively collaborate with cross-functional teams and external stakeholders.
• Strong leadership skills, with the ability to motivate and inspire teams to achieve ambitious goals and drive results.
• Detail-oriented with strong analytical and problem-solving abilities.
• Ability to thrive in a fast-paced and dynamic environment with a proactive and adaptable approach to challenges.
  
  

Cullinan Therapeutics is proud to be an Equal Opportunity Employer. We are committed to creating an inclusive and diverse environment for all employees and applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.